R172
Showing 1 - 25 of 2,027
Safety, Tolerability, Ocular Surface Trial in Guadalajara (Bepotastine Besilate)
Completed
- Safety
- +3 more
- Bepotastine Besilate
-
Guadalajara, Jalisco, MexicoUnidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 22, 2021
MDS Trial in Worldwide (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Los Alamitos, California
- +53 more
Sep 13, 2023
Uncontrolled Hypertension, Resistant Hypertension Trial in Worldwide (Baxdrostat, Placebo)
Not yet recruiting
- Uncontrolled Hypertension
- Resistant Hypertension
- Baxdrostat
- Placebo
-
Saraland, Alabama
- +122 more
Sep 6, 2023
Parkinson's Disease (Disorder) Trial in Worldwide (IR CD-LD, IPX203 ER CD-LD, IPX203 )
Completed
- Parkinson's Disease (Disorder)
- IR CD-LD
- +3 more
-
Phoenix, Arizona
- +107 more
Jul 22, 2021
Generalized Myasthenia Gravis Trial in Worldwide (Pozelimab + Cemdisiran, Cemdisiran, Placebo)
Recruiting
- Generalized Myasthenia Gravis
- Pozelimab + Cemdisiran
- +3 more
-
Phoenix, Arizona
- +46 more
Jan 31, 2023
Process for Hepatocellular Carcinoma
Not yet recruiting
- Hepatocellular Carcinoma
- (no location specified)
May 5, 2023
Pneumothorax Trial in Taoyuan City (Chang Gung Pneumothorax Detection Software)
Not yet recruiting
- Pneumothorax
- Chang Gung Pneumothorax Detection Software
-
Taoyuan City, TaiwanChang Gung memorial hospital
Jun 6, 2023
IDH2 Mutations and Monitoring Molecular Residual Disease in AML
Enrolling by invitation
- Acute Myeloid Leukemia
-
Taoyuan, State, TaiwanChang Gung Memorial Hospital-Linkou
Aug 4, 2021
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)
Active, not recruiting
- Renal Cell Carcinoma
- Cabozantinib
- +3 more
-
La Jolla, California
- +159 more
Jan 23, 2023
HIV, Cognitive Impairment Trial in Birmingham, Aurora, Seattle (Phase 1 Gym Exercise HIIT, Phase 1 Gym Exercise CME, Phase 2
Not yet recruiting
- HIV Infections
- Cognitive Impairment
- Phase 1 Gym Exercise HIIT
- +3 more
-
Birmingham, Alabama
- +2 more
Aug 22, 2023
Recurrent Acute Myeloid Leukemia Trial in United States (Enasidenib Mesylate, Liposome-encapsulated Daunorubicin-Cytarabine)
Suspended
- Recurrent Acute Myeloid Leukemia
- Enasidenib Mesylate
- Liposome-encapsulated Daunorubicin-Cytarabine
-
Los Angeles, California
- +3 more
Sep 27, 2022
Participation for Small Cell Lung Cancer Patients
Not yet recruiting
- Small Cell Lung Cancer
- (no location specified)
Mar 3, 2023
Program for Primary Biliary Cholangitis Lost in the System
Recruiting
- Primary Biliary Cholangitis
-
Terrassa, Barcelona, SpainHospital Universitari MútuaTerrassa
Jun 16, 2023
Perioperative Parameter and Treatment Outcomes of ECIRS in Asia
Not yet recruiting
- Renal Stone
- ECIRS
-
Hong Kong, Hong Kong
- +2 more
Jun 7, 2023
Decreasing On-Shift Stress With a Crisis Intervention Cart Trial in Dallas (Aromatherapy patches)
Recruiting
- Decreasing On-Shift Stress With a Crisis Intervention Cart
- Aromatherapy patches
-
Dallas, TexasMethodist Dallas Medical Center
Jul 6, 2023
Patients Treated With PuraBond Haemostatic Agent During
Recruiting
- Hemostatic
- Purabond
-
Milano, ItalyIRCCS San Raffaele Hospital
Feb 21, 2023
Impacted Canine Trial in Damascus (Fixed appliances, Corticotomy)
Completed
- Impacted Canine
- Fixed appliances
- Corticotomy
-
Damascus, Syrian Arab RepublicUniversity of Damascus
Dec 11, 2022
Epidemiology of Sleep-Disordered Breathing in Adults
Active, not recruiting
- Sleep Disorders
- +4 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Jan 23, 2023
Stress Disorders, Post-Traumatic Trial in Dayton (EEG-based personalized TMS)
Recruiting
- Stress Disorders, Post-Traumatic
- EEG-based personalized TMS
-
Dayton, OhioWright State University
Oct 13, 2023
Adult Eating Disorder Assessment Study
Not yet recruiting
- Eating Disorders
-
Leicester, United KingdomLeicestershire Partnership NHS Trust
Oct 24, 2023
The Learning Curve for Retroperitoneoscopic Donor Nephrectomy
Completed
- Transplant;Failure,Kidney
-
Samsun, TurkeyOndokuz Mayıs University, Department of Urology
Mar 16, 2023
Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))
Recruiting
- Duchenne Muscular Dystrophy
- Phase 1, SQY51
- +3 more
-
Garches, FranceHôpital Raymond Poincaré
Mar 7, 2023
sST2 and Troponin I-hs in Patients With Acute Chest Pain
Active, not recruiting
- Acute Chest Pain
- Acute Coronary Syndrome
- Multimarker approach in acute coronary syndrome
-
Roma, ItalySilvia Baroni
Feb 21, 2023
Epilepsy, Temporal Lobe, Cognitive Decline Trial in Nancy (functional MRI)
Recruiting
- Epilepsy, Temporal Lobe
- Cognitive Decline
- functional MRI
-
Nancy, FranceCentre Hospitalier Régional Universitaire de Nancy
Jan 17, 2023
Laser Hysteroscopic Ablation of Submucous Myoma Trial in Barcelona (hysteroscopic ablation of submucous uterine fibroid using
Completed
- Laser Hysteroscopic Ablation of Submucous Myoma
- hysteroscopic ablation of submucous uterine fibroid using diode laser
-
Barcelona, SpainParc de Salut Mar
Nov 3, 2022